Taiwan FDA registration 2984b4c17c9c168bc1f27d7039847aff
LZI THC (Cannabinoid) EIA Kit
TW: 靈芝大麻酵素免疫試劑
Taiwan·Risk Class 2·MD·LIN-ZHI INTERNATIONAL, INC·Registered Dec 13, 2018 – Dec 13, 2023ExpiredRegistration details
- Analysis ID
- 2984b4c17c9c168bc1f27d7039847aff
- License Form
- Ministry of Health Medical Device Import No. 031959
- Customs Code
- DHA05603195906
Company information
- Manufacturer
- LIN-ZHI INTERNATIONAL, INC
- Manufacturer Country
- United States
- Authorized Representative
- TAIWAN ADVANCE BIO-PHARMACEUTICAL INC.
Product details
- Intended Use
- The content of cannabis in human urine is determined qualitatively or semi-quantitatively, with a threshold of 50 ng/mL.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A3870 Cannabinoid Test System
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Dec 13, 2018
- Expiry Date
- Dec 13, 2023
About this record
Access comprehensive regulatory information for LZI THC (Cannabinoid) EIA Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2984b4c17c9c168bc1f27d7039847aff and manufactured by LIN-ZHI INTERNATIONAL, INC. The authorized representative in Taiwan is TAIWAN ADVANCE BIO-PHARMACEUTICAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices